Cysteine Protease Cathepsins in Atherosclerosis-Based Vascular Disease and Its Complications
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Atherosclerosis-based vascular disease is an inflammatory disease characterized by extensive remodeling of the extracellular matrix architecture of the arterial wall. Although matrix metalloproteinases and serine proteases participate in these pathological events, the discovery of cysteine protease cathepsins, such as cathepsins K, S, L, and B, and cystatin C, and their tissue distribution has suggested that at least some of them participate in cardiovascular disease. Studies on vascular cells have shown that atherosclerosis-associated inflammatory cytokines augment cysteinyl cathepsin expression and activity. Novel insight into cathepsin functions has been made possible by the generation and in-depth analysis of knockout and transgenic mice. These studies have provided direct evidence implicating cathepsins in atherosclerosis-based vascular disease through the activation, liberation, and modification of angiogenic growth factors, cytokines, and proteases associated with lipid metabolism, cell events (migration, invasion, proliferation, and apoptosis), angiogenesis, and matrix protein remodeling. Furthermore, evaluation of the feasibility of cathepsins as a diagnostic tool has revealed that the serum cathepsins S and L and the endogenous inhibitor cystatin C hold promise as biomarkers of coronary artery disease and aneurysm formation. The goal of this review is to summarize the available information regarding the mechanistic contributions of cathepsins in atherosclerosis-based vascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumoto, M., Kogawa, M., Wada, S., Takayanagi, H., Tsujimoto, M., Katayama, S., Hisatake, K., & Nogi, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408795200 · Cited by 436
Droga-Mazovec, G., Bojič, L., Petelin, A., Ivanova, S., Romih, R., Repnik, U., Salvesen, G. S., Stoka, V., Turk, V., & Turk, B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802513200 · Cited by 399
“Thyroid functions of mouse cathepsins b, K and l
Friedrichs, B., Tepel, C., Reinheckel, T., Deussing, J., von Figura, K., Herzog, V., Peters, C., Saftig, P., & Brix, K. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15990 · Cited by 226
Cited by
The lysosome: from waste bag to potential therapeutic target
Appelqvist, H., Wäster, P., Kågedal, K., & Öllinger, K. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt022 · Cited by 772
Cysteine cathepsins and extracellular matrix degradation
Fonović, M., & Turk, B. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.03.017 · Cited by 345
Elastolytic activity of cysteine cathepsins K, S, and V promotes vascular calcification
Andrault, P.-M., Panwar, P., Mackenzie, N. C. W., & Brömme, D. (2019) · Scientific Reports · doi:10.1038/s41598-019-45918-1 · Cited by 43
Increased levels of lysosomal cysteinyl cathepsins in human varicose veins: a histology study
Xu, N., Zhang, Y.-Y., Lin, Y., Bao, B., Zheng, L., Shi, G.-P., & Liu, J. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-04-0309 · Cited by 15
“In AAA and atherosclerosis lesions, various inflam- matory cells, including monocytes/macrophages, T cells, and MCs, participate in vascular ECM remodelling by releasing inflammatory cytokines to regulate vascular cell cathepsin expression or by directly releasing cathepsins (11, 18, 24).”
BackgroundInfluentialA phenome-wide structural variant map from 467,152 UK Biobank genomes
Atanur, S. S., Hu, F., Lou, H., Li, X., Zou, X. Z., O’Dell, S., Deevi, S. V. V., Sawczuk, P., Megy, K., Fairhurst-Hunter, Z., et al. (2026) · Cell · doi:10.1016/j.cell.2026.09.035
Metadata
- Authors
- Cheng, X. W., Huang, Z., Kuzuya, M., Okumura, K., & Murohara, T.
- Venue
- Hypertension
- Published
- 2011-12
- Volume
- 58
- Issue
- 6
- Pages
- 978-986
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2122308023
- Cited by
- 138
- References
- 3
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cysteine Protease Cathepsins in Atherosclerosis-Based Vascular Disease and Its Complications. https://app.cochat.ai/papers/10.1161/hypertensionaha.111.180935
- The paper
- Cheng, X. W., Huang, Z., Kuzuya, M., Okumura, K., & Murohara, T. (2011). Cysteine Protease Cathepsins in Atherosclerosis-Based Vascular Disease and Its Complications. Hypertension. https://doi.org/10.1161/hypertensionaha.111.180935
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.